This functionality is implemented using Javascript. It cannot work without it, etc...

Estamos cargando la información...

Saltar al contenido

Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

ID Título Última Revisión Siguiente Revisión Descripción Acceso
11.003.032 Analysis Of Human Dna In Stool Samples As A Technique For Colorectal Cancer Screening Jan 20, 2025 Jan 20, 2026 Of safety and effectiveness data (ssed): cologuard. august 2014. accessed oct 21,... Ver
11.003.033 Análisis de los patrones proteómicos séricos para identificar el cáncer de ovari May 12, 2016 Policy Archived ... Ver
11.003.034 Genetic And Protein Biomarkers For The Diagnosis And Cancer Risk Assessment Of Prostate Cancer Dec 20, 2024 Dec 20, 2025 Various genetic and protein biomarkers are associated with prostate cancer. these tests have the potential to... Ver
11.003.035 Assays Of Genetic Expression In Tumor Tissue As A Technique To Determine Prognosis In Patients With Breast Cancer Dec 06, 2024 Dec 20, 2025 Laboratory tests have been developed to detect the expression, via messenger rna, of different genes in... Ver
11.003.036 Genetic Testing For Familial Cutaneous Malignant Melanoma Apr 18, 2025 Apr 20, 2026 Cutaneous melanoma is the third most common type of skin cancer, but the most lethal. some cases of cutaneous... Ver
11.003.037 Novel Biomarkers In Risk Assessment And Management Of Cardiovascular Disease Jan 20, 2025 Jan 20, 2026 Numerous lipid and non-lipid biomarkers have been proposed as potential risk markers for cardiovascular... Ver
11.003.038 Biomarker Genes For Detection Of Lymph Node Metastases In Breast Cancer May 15, 2019 Policy Archived As highlighted in a 2008 editorial, the ongoing difficulties with using molecular techniques to detect... Ver
11.003.039 Pharmacogenomic And Metabolite Markers For Patients Treated With Thiopurines Dec 20, 2024 Dec 20, 2025 The thiopurine class of drugs, which include azathioprine (a pro-drug for mercaptopurine), mercaptopurine,... Ver
11.003.040 Genetic Testing For Alzheimer Disease Nov 22, 2024 Nov 20, 2025 Alzheimer disease (ad) is the most common cause of dementia in elderly patients. for late-onset ad, there is... Ver
11.003.042 Genetic Testing For Cardiac Ion Channelopathies Feb 18, 2025 Feb 20, 2026 Genetic testing is available for patients suspected of having cardiac ion channelopathies, including long qt... Ver
11.003.046 Genetic Testing For Fmr1 Variants (Including Fragile X Syndrome) Feb 20, 2025 Feb 20, 2026 Fragile x syndrome (fxs) is the most common inherited form of mental disability and a known genetic cause of... Ver
11.003.047 Gene Expression-Based Assays For Cancers Of Unknown Primary May 09, 2025 May 20, 2026 Cancers of unknown primary represent 3% to 4% of cancers diagnosed in the united states. these cancers are... Ver
11.003.048 Carrier Screening For Genetic Diseases Oct 10, 2024 Oct 20, 2025 Carrier screening is performed to identify individuals at risk of having offspring with inherited recessive... Ver
11.003.049 Genetic Testing For Diagnosis And Management Of Mental Health Conditions Aug 20, 2024 Aug 20, 2025 Individual genes have been shown to be associated with the risk of psychiatric disorders and specific aspects... Ver
11.003.050 Genetic Testing For Epilepsy Apr 14, 2025 Apr 20, 2026 Epilepsy is a disorder characterized by unprovoked seizures. it is a heterogeneous condition that encompasses... Ver
11.003.051 Gene Expression Profiling And Protein Biomarkers For Prostate Cancer Management May 05, 2025 May 20, 2026 Gene expression profile analysis and protein biomarkers have been proposed as a means to risk-stratify... Ver
11.003.052 Molecular Markers In Fine Needle Aspirates Of The Thyroid Sep 24, 2024 Sep 20, 2025 To determine which patients need thyroid resection, many physicians will perform a cytologic examination of... Ver
11.003.053 Whole Exome And Whole Genome Sequencing For Diagnosis Of Genetic Disorders Apr 22, 2025 Apr 20, 2026 Whole exome sequencing (wes) sequences the portion of the genome that contains protein-coding dna, while... Ver
11.003.056 Genetic Testing For A Thalassemia Jul 10, 2024 Jul 20, 2025 Alpha-thalassemia represents a group of clinical syndromes of varying severity characterized by hemolytic... Ver
11.003.057 Genetic Testing For Fanconi Anemia Jan 15, 2025 Jan 20, 2026 Fanconi anemia (fa) is an inherited disorder characterized by congenital abnormalities, bone marrow failure,... Ver
787-277-6653 787-474-6326